{"transactions":[{"id":4620998,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37234,"kind":"person","name":"DENNER ALEXANDER J","position":1,"cik":"0001361754","reported_name":"DENNER ALEXANDER J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-09-17T20:05:30.000Z","date":"2026-09-15","kind":"grant","planned":false,"acquired":true,"shares":3694,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024."}],"balance_after":327549,"source":{"system":"sec-edgar","filing":"0001193125-26-394323","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000119312526394323/ownership.xml","form_type":"4"}},{"id":704690,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29151,"kind":"person","name":"Silber Jeffrey","position":1,"cik":"0002050938","reported_name":"Silber Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CMO, Head-Res&Drug"}}],"security":"Class A Common Stock","published_at":"2026-07-22T20:10:04.000Z","date":"2026-07-20","kind":"grant","planned":false,"acquired":true,"shares":137036,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock unit award, granted as a new hire award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof."}],"balance_after":137036,"source":{"system":"sec-edgar","filing":"0001193125-26-312410","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000119312526312410/ownership.xml","form_type":"4"}},{"id":711783,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":31202,"kind":"person","name":"Silver Ronald","position":1,"cik":"0001873731","reported_name":"Silver Ronald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PFO & PAO"}}],"security":"Class A Common Stock","published_at":"2026-07-09T20:32:49.000Z","date":"2026-07-07","kind":"sale","planned":true,"acquired":false,"shares":127890,"price":4.52,"value":578062.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.50 to $4.57, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":313680,"source":{"system":"sec-edgar","filing":"0001193125-26-299749","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000119312526299749/ownership.xml","form_type":"4"}},{"id":733959,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":30802,"kind":"person","name":"Shepard Jay","position":1,"cik":"0001587788","reported_name":"Shepard Jay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-17T20:47:05.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":63481,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":235036,"source":{"system":"sec-edgar","filing":"0001193125-26-274301","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000119312526274301/ownership.xml","form_type":"4"}},{"id":733958,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37236,"kind":"person","name":"Kessler Marla L","position":1,"cik":"0001772124","reported_name":"Kessler Marla L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-17T20:45:20.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":63481,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":229364,"source":{"system":"sec-edgar","filing":"0001193125-26-274292","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000119312526274292/ownership.xml","form_type":"4"}},{"id":734016,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37245,"kind":"person","name":"Currie Mark G","position":1,"cik":"0001478244","reported_name":"Currie Mark G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-17T20:44:20.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":63481,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":676900,"source":{"system":"sec-edgar","filing":"0001193125-26-274288","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478244/000119312526274288/ownership.xml","form_type":"4"}},{"id":733957,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37235,"kind":"person","name":"Duane Jon R","position":1,"cik":"0001772129","reported_name":"Duane Jon R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-17T20:43:18.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":63481,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":253820,"source":{"system":"sec-edgar","filing":"0001193125-26-274283","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000119312526274283/ownership.xml","form_type":"4"}},{"id":733956,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37234,"kind":"person","name":"DENNER ALEXANDER J","position":1,"cik":"0001361754","reported_name":"DENNER ALEXANDER J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-17T20:42:25.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":63481,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":323855,"source":{"system":"sec-edgar","filing":"0001193125-26-274279","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000119312526274279/ownership.xml","form_type":"4"}},{"id":733955,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37234,"kind":"person","name":"DENNER ALEXANDER J","position":1,"cik":"0001361754","reported_name":"DENNER ALEXANDER J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-17T20:42:25.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":4065,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024."}],"balance_after":260374,"source":{"system":"sec-edgar","filing":"0001193125-26-274279","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000119312526274279/ownership.xml","form_type":"4"}},{"id":734032,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-17T20:41:40.000Z","date":"2026-06-16","kind":"sale","planned":true,"acquired":false,"shares":21571,"price":3.73,"value":80459.83,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.66 to $3.78, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":250749,"source":{"system":"sec-edgar","filing":"0001193125-26-274275","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000119312526274275/ownership.xml","form_type":"4"}},{"id":734031,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-17T20:41:40.000Z","date":"2026-06-16","kind":"grant","planned":true,"acquired":true,"shares":63481,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":272320,"source":{"system":"sec-edgar","filing":"0001193125-26-274275","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000119312526274275/ownership.xml","form_type":"4"}},{"id":733954,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":36673,"kind":"person","name":"Moukheibir Catherine","position":1,"cik":"0001772130","reported_name":"Moukheibir Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-17T20:36:28.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":63481,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":181425,"source":{"system":"sec-edgar","filing":"0001193125-26-274256","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000119312526274256/ownership.xml","form_type":"4"}},{"id":767841,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":31202,"kind":"person","name":"Silver Ronald","position":1,"cik":"0001873731","reported_name":"Silver Ronald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PFO & PAO"}}],"security":"Common Stock","published_at":"2026-05-21T20:05:21.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock unit award vests as to 50% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof."}],"balance_after":441570,"source":{"system":"sec-edgar","filing":"0001193125-26-234397","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000119312526234397/ownership.xml","form_type":"4"}},{"id":837730,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37234,"kind":"person","name":"DENNER ALEXANDER J","position":1,"cik":"0001361754","reported_name":"DENNER ALEXANDER J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-18T00:34:48.000Z","date":"2026-03-17","kind":"sale","planned":false,"acquired":false,"shares":5800,"price":3.31,"value":19198.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Consists of shares that are held by Sarissa Capital Management LP (\"Sarissa Capital\") or by the funds and other investment vehicles (the \"Sarissa Funds\") for which Sarissa Capital serves as investment advisor. Dr. Denner is the Chief Investment Officer of Sarissa Capital and the managing member, general partner or other control party of the Sarissa Funds. By virtue of the foregoing, Dr. Denner may be deemed to indirectly beneficially own the shares that these funds directly beneficially own. Each of SarissaCapital, the Sarissa Funds and Dr. Denner disclaims beneficial ownership of these shares except, in each case, to the extent of their pecuniary interest therein."}],"balance_after":9188635,"source":{"system":"sec-edgar","filing":"0001193125-26-111581","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000119312526111581/ownership.xml","form_type":"4"}},{"id":837729,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37234,"kind":"person","name":"DENNER ALEXANDER J","position":1,"cik":"0001361754","reported_name":"DENNER ALEXANDER J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-18T00:34:48.000Z","date":"2026-03-17","kind":"sale","planned":false,"acquired":false,"shares":6725000,"price":3.05,"value":20511250.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Consists of shares that are held by Sarissa Capital Management LP (\"Sarissa Capital\") or by the funds and other investment vehicles (the \"Sarissa Funds\") for which Sarissa Capital serves as investment advisor. Dr. Denner is the Chief Investment Officer of Sarissa Capital and the managing member, general partner or other control party of the Sarissa Funds. By virtue of the foregoing, Dr. Denner may be deemed to indirectly beneficially own the shares that these funds directly beneficially own. Each of SarissaCapital, the Sarissa Funds and Dr. Denner disclaims beneficial ownership of these shares except, in each case, to the extent of their pecuniary interest therein."}],"balance_after":9194435,"source":{"system":"sec-edgar","filing":"0001193125-26-111581","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000119312526111581/ownership.xml","form_type":"4"}},{"id":837728,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37234,"kind":"person","name":"DENNER ALEXANDER J","position":1,"cik":"0001361754","reported_name":"DENNER ALEXANDER J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-03-18T00:34:48.000Z","date":"2026-03-13","kind":"grant","planned":false,"acquired":true,"shares":4451,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024."}],"balance_after":256309,"source":{"system":"sec-edgar","filing":"0001193125-26-111581","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000119312526111581/ownership.xml","form_type":"4"}},{"id":846644,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":45734,"kind":"person","name":"Martini Gregory S.","position":1,"cik":"0002053936","reported_name":"Martini Gregory S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-12T20:05:11.000Z","date":"2026-03-10","kind":"grant","planned":false,"acquired":true,"shares":136612,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof."}],"balance_after":297213,"source":{"system":"sec-edgar","filing":"0001193125-26-104107","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2053936/000119312526104107/ownership.xml","form_type":"4"}},{"id":845944,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":61225,"kind":"person","name":"Gaskins Tammi L","position":1,"cik":"0002061679","reported_name":"Gaskins Tammi L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-12T20:05:09.000Z","date":"2026-03-10","kind":"grant","planned":false,"acquired":true,"shares":136612,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof."}],"balance_after":350350,"source":{"system":"sec-edgar","filing":"0001193125-26-104112","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000119312526104112/ownership.xml","form_type":"4"}},{"id":845942,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":31202,"kind":"person","name":"Silver Ronald","position":1,"cik":"0001873731","reported_name":"Silver Ronald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-12T20:05:05.000Z","date":"2026-03-10","kind":"grant","planned":false,"acquired":true,"shares":163934,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof."}],"balance_after":416570,"source":{"system":"sec-edgar","filing":"0001193125-26-104110","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000119312526104110/ownership.xml","form_type":"4"}},{"id":846413,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":61273,"kind":"person","name":"John Minardo","position":1,"cik":"0001875067","reported_name":"John Minardo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-12T16:05:13.000Z","date":"2026-03-10","kind":"grant","planned":false,"acquired":true,"shares":136612,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof."}],"balance_after":500498,"source":{"system":"sec-edgar","filing":"0001193125-26-104108","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875067/000119312526104108/ownership.xml","form_type":"4"}},{"id":847187,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":61367,"kind":"person","name":"Shetzline Michael","position":1,"cik":"0001808509","reported_name":"Shetzline Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CMO, Head-Res&Drug"}}],"security":"Class A Common Stock","published_at":"2026-03-12T16:05:07.000Z","date":"2026-03-10","kind":"grant","planned":false,"acquired":true,"shares":136612,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof."}],"balance_after":658037,"source":{"system":"sec-edgar","filing":"0001193125-26-104111","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808509/000119312526104111/ownership.xml","form_type":"4"}},{"id":846030,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-12T16:05:04.000Z","date":"2026-03-10","kind":"grant","planned":false,"acquired":true,"shares":409836,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock unit award, granted as an annual performance award, vests as to 33.33% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof."}],"balance_after":1898838,"source":{"system":"sec-edgar","filing":"0001193125-26-104099","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000119312526104099/ownership.xml","form_type":"4"}},{"id":881808,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":61225,"kind":"person","name":"Gaskins Tammi L","position":1,"cik":"0002061679","reported_name":"Gaskins Tammi L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-25T21:05:10.000Z","date":"2026-02-24","kind":"sale","planned":false,"acquired":false,"shares":11239,"price":3.66,"value":41134.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.60 to $3.73, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":213738,"source":{"system":"sec-edgar","filing":"0001193125-26-071500","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000119312526071500/ownership.xml","form_type":"4"}},{"id":881807,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":61225,"kind":"person","name":"Gaskins Tammi L","position":1,"cik":"0002061679","reported_name":"Gaskins Tammi L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-25T21:05:10.000Z","date":"2026-02-23","kind":"sale","planned":false,"acquired":false,"shares":10287,"price":3.81,"value":39193.47,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.70 to $4.05, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":224977,"source":{"system":"sec-edgar","filing":"0001193125-26-071500","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000119312526071500/ownership.xml","form_type":"4"}},{"id":882331,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":45734,"kind":"person","name":"Martini Gregory S.","position":1,"cik":"0002053936","reported_name":"Martini Gregory S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-25T21:05:06.000Z","date":"2026-02-24","kind":"sale","planned":false,"acquired":false,"shares":11457,"price":3.66,"value":41932.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.60 to $3.73, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":160601,"source":{"system":"sec-edgar","filing":"0001193125-26-071515","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2053936/000119312526071515/ownership.xml","form_type":"4"}},{"id":882330,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":45734,"kind":"person","name":"Martini Gregory S.","position":1,"cik":"0002053936","reported_name":"Martini Gregory S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-25T21:05:06.000Z","date":"2026-02-23","kind":"sale","planned":false,"acquired":false,"shares":10487,"price":3.81,"value":39955.47,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.70 to $4.05, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":172058,"source":{"system":"sec-edgar","filing":"0001193125-26-071515","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2053936/000119312526071515/ownership.xml","form_type":"4"}},{"id":881806,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":31202,"kind":"person","name":"Silver Ronald","position":1,"cik":"0001873731","reported_name":"Silver Ronald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-25T21:05:04.000Z","date":"2026-02-24","kind":"sale","planned":false,"acquired":false,"shares":12621,"price":3.66,"value":46192.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.60 to $3.73, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":252636,"source":{"system":"sec-edgar","filing":"0001193125-26-071495","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000119312526071495/ownership.xml","form_type":"4"}},{"id":881805,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":31202,"kind":"person","name":"Silver Ronald","position":1,"cik":"0001873731","reported_name":"Silver Ronald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-25T21:05:04.000Z","date":"2026-02-23","kind":"sale","planned":false,"acquired":false,"shares":11552,"price":3.81,"value":44013.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.70 to $4.05, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":265257,"source":{"system":"sec-edgar","filing":"0001193125-26-071495","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000119312526071495/ownership.xml","form_type":"4"}},{"id":882180,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":61273,"kind":"person","name":"John Minardo","position":1,"cik":"0001875067","reported_name":"John Minardo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-25T16:05:22.000Z","date":"2026-02-24","kind":"sale","planned":false,"acquired":false,"shares":19053,"price":3.66,"value":69733.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.60 to $3.73, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":363886,"source":{"system":"sec-edgar","filing":"0001193125-26-071509","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875067/000119312526071509/ownership.xml","form_type":"4"}},{"id":882179,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":61273,"kind":"person","name":"John Minardo","position":1,"cik":"0001875067","reported_name":"John Minardo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-25T16:05:22.000Z","date":"2026-02-23","kind":"sale","planned":false,"acquired":false,"shares":17439,"price":3.81,"value":66442.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.70 to $4.05, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":382939,"source":{"system":"sec-edgar","filing":"0001193125-26-071509","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875067/000119312526071509/ownership.xml","form_type":"4"}},{"id":882699,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":61367,"kind":"person","name":"Shetzline Michael","position":1,"cik":"0001808509","reported_name":"Shetzline Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CMO, Head-Res&Drug"}}],"security":"Common Stock","published_at":"2026-02-25T16:05:17.000Z","date":"2026-02-24","kind":"sale","planned":false,"acquired":true,"shares":17012,"price":3.66,"value":62263.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.60 to $3.73, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":521425,"source":{"system":"sec-edgar","filing":"0001193125-26-071503","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808509/000119312526071503/ownership.xml","form_type":"4"}},{"id":882698,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":61367,"kind":"person","name":"Shetzline Michael","position":1,"cik":"0001808509","reported_name":"Shetzline Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CMO, Head-Res&Drug"}}],"security":"Class A Common Stock","published_at":"2026-02-25T16:05:17.000Z","date":"2026-02-23","kind":"sale","planned":false,"acquired":false,"shares":15570,"price":3.81,"value":59321.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.70 to $4.05, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":538437,"source":{"system":"sec-edgar","filing":"0001193125-26-071503","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808509/000119312526071503/ownership.xml","form_type":"4"}},{"id":881892,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-25T16:05:07.000Z","date":"2026-02-24","kind":"sale","planned":false,"acquired":false,"shares":103526,"price":3.66,"value":378905.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.60 to $3.73, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":1489002,"source":{"system":"sec-edgar","filing":"0001193125-26-071496","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000119312526071496/ownership.xml","form_type":"4"}},{"id":881891,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-25T16:05:07.000Z","date":"2026-02-23","kind":"sale","planned":false,"acquired":false,"shares":94757,"price":3.81,"value":361024.17,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.70 to $4.05, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The reporting person acquired 4 shares of Class A Common Stock under the issuer's employee stock purchase plan on December 31, 2025."}],"balance_after":1592528,"source":{"system":"sec-edgar","filing":"0001193125-26-071496","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000119312526071496/ownership.xml","form_type":"4"}},{"id":944353,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":31202,"kind":"person","name":"Silver Ronald","position":1,"cik":"0001873731","reported_name":"Silver Ronald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Class A Common Stock","published_at":"2026-01-07T21:05:09.000Z","date":"2026-01-05","kind":"sale","planned":true,"acquired":false,"shares":35416,"price":4.6,"value":162913.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person acquired 35,416 shares of Class A Common Stock under the issuer's employee stock purchase plan on December 31, 2025."}],"balance_after":276809,"source":{"system":"sec-edgar","filing":"0001193125-26-006290","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000119312526006290/ownership.xml","form_type":"4"}},{"id":964867,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37234,"kind":"person","name":"DENNER ALEXANDER J","position":1,"cik":"0001361754","reported_name":"DENNER ALEXANDER J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71303,"kind":"organization","name":"Sarissa Capital Management LP","position":2,"cik":"0001577524","reported_name":"Sarissa Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-12-17T21:05:07.000Z","date":"2025-12-15","kind":"grant","planned":false,"acquired":true,"shares":4178,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024."}],"balance_after":251858,"source":{"system":"sec-edgar","filing":"0001193125-25-322690","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000119312525322690/ownership.xml","form_type":"4"}},{"id":993719,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":61225,"kind":"person","name":"Gaskins Tammi L","position":1,"cik":"0002061679","reported_name":"Gaskins Tammi L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2025-11-19T21:05:04.000Z","date":"2025-11-17","kind":"sale","planned":false,"acquired":false,"shares":6016,"price":3.32,"value":19973.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":235264,"source":{"system":"sec-edgar","filing":"0001193125-25-288086","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000119312525288086/ownership.xml","form_type":"4"}},{"id":1037678,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37234,"kind":"person","name":"DENNER ALEXANDER J","position":1,"cik":"0001361754","reported_name":"DENNER ALEXANDER J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-09-18T00:28:54.000Z","date":"2025-09-15","kind":"grant","planned":false,"acquired":true,"shares":11718,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024."}],"balance_after":247680,"source":{"system":"sec-edgar","filing":"0001193125-25-206547","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000119312525206547/ownership.xml","form_type":"4"}},{"id":1067695,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":61225,"kind":"person","name":"Gaskins Tammi L","position":1,"cik":"0002061679","reported_name":"Gaskins Tammi L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2025-08-13T20:05:09.000Z","date":"2025-08-11","kind":"sale","planned":false,"acquired":false,"shares":1316,"price":0.84,"value":1105.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":241280,"source":{"system":"sec-edgar","filing":"0000950170-25-108016","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017025108016/ownership.xml","form_type":"4"}},{"id":1068000,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":45734,"kind":"person","name":"Martini Gregory S.","position":1,"cik":"0002053936","reported_name":"Martini Gregory S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-08-13T20:05:05.000Z","date":"2025-08-11","kind":"sale","planned":false,"acquired":false,"shares":1265,"price":0.84,"value":1062.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":182545,"source":{"system":"sec-edgar","filing":"0000950170-25-108010","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2053936/000095017025108010/ownership.xml","form_type":"4"}},{"id":1067696,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":31202,"kind":"person","name":"Silver Ronald","position":1,"cik":"0001873731","reported_name":"Silver Ronald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Class A Common Stock","published_at":"2025-08-13T20:05:04.000Z","date":"2025-08-11","kind":"sale","planned":false,"acquired":false,"shares":2846,"price":0.84,"value":2390.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":276809,"source":{"system":"sec-edgar","filing":"0000950170-25-108011","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017025108011/ownership.xml","form_type":"4"}},{"id":1067929,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":61273,"kind":"person","name":"John Minardo","position":1,"cik":"0001875067","reported_name":"John Minardo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Class A Common Stock","published_at":"2025-08-13T16:05:08.000Z","date":"2025-08-11","kind":"sale","planned":false,"acquired":false,"shares":7754,"price":0.84,"value":6513.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":400378,"source":{"system":"sec-edgar","filing":"0000950170-25-108013","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875067/000095017025108013/ownership.xml","form_type":"4"}},{"id":1107855,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37234,"kind":"person","name":"DENNER ALEXANDER J","position":1,"cik":"0001361754","reported_name":"DENNER ALEXANDER J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71303,"kind":"organization","name":"Sarissa Capital Management LP","position":2,"cik":"0001577524","reported_name":"Sarissa Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-06-17T20:05:10.000Z","date":"2025-06-13","kind":"grant","planned":false,"acquired":true,"shares":24193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024."}],"balance_after":235962,"source":{"system":"sec-edgar","filing":"0000950170-25-087350","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017025087350/ownership.xml","form_type":"4"}},{"id":1113222,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37236,"kind":"person","name":"Kessler Marla L","position":1,"cik":"0001772124","reported_name":"Kessler Marla L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-06-12T20:28:30.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":165883,"source":{"system":"sec-edgar","filing":"0000950170-25-085452","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017025085452/ownership.xml","form_type":"4"}},{"id":1113220,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":30802,"kind":"person","name":"Shepard Jay","position":1,"cik":"0001587788","reported_name":"Shepard Jay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-06-12T20:28:05.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":171555,"source":{"system":"sec-edgar","filing":"0000950170-25-085448","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017025085448/ownership.xml","form_type":"4"}},{"id":1113221,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":36673,"kind":"person","name":"Moukheibir Catherine","position":1,"cik":"0001772130","reported_name":"Moukheibir Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-06-12T20:27:41.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":117944,"source":{"system":"sec-edgar","filing":"0000950170-25-085446","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017025085446/ownership.xml","form_type":"4"}},{"id":1113218,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37235,"kind":"person","name":"Duane Jon R","position":1,"cik":"0001772129","reported_name":"Duane Jon R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-06-12T20:27:21.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":190339,"source":{"system":"sec-edgar","filing":"0000950170-25-085443","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017025085443/ownership.xml","form_type":"4"}},{"id":1113288,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37245,"kind":"person","name":"Currie Mark G","position":1,"cik":"0001478244","reported_name":"Currie Mark G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-06-12T20:27:03.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":613419,"source":{"system":"sec-edgar","filing":"0000950170-25-085440","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478244/000095017025085440/ownership.xml","form_type":"4"}},{"id":1113292,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-06-12T20:26:42.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":208839,"source":{"system":"sec-edgar","filing":"0000950170-25-085438","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000095017025085438/ownership.xml","form_type":"4"}},{"id":1113326,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":47389,"kind":"person","name":"Dreyfus Andrew","position":1,"cik":"0001670893","reported_name":"Dreyfus Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-06-12T20:26:22.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Since the date of the reporting person's last ownership report, the individual transferred 4,917 shares of Class A common stock to the individual's ex-spouse pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by the individual's ex-spouse."}],"balance_after":228313,"source":{"system":"sec-edgar","filing":"0000950170-25-085437","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670893/000095017025085437/ownership.xml","form_type":"4"}},{"id":1113219,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37234,"kind":"person","name":"DENNER ALEXANDER J","position":1,"cik":"0001361754","reported_name":"DENNER ALEXANDER J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71303,"kind":"organization","name":"Sarissa Capital Management LP","position":2,"cik":"0001577524","reported_name":"Sarissa Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-06-12T20:17:24.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":211769,"source":{"system":"sec-edgar","filing":"0000950170-25-085378","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017025085378/ownership.xml","form_type":"4"}},{"id":1140352,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":61225,"kind":"person","name":"Gaskins Tammi L","position":1,"cik":"0002061679","reported_name":"Gaskins Tammi L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2025-05-20T20:10:39.000Z","date":"2025-05-16","kind":"sale","planned":false,"acquired":false,"shares":2563,"price":0.58,"value":1486.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":242596,"source":{"system":"sec-edgar","filing":"0000950170-25-075183","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017025075183/ownership.xml","form_type":"4"}},{"id":1140384,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-05-20T16:14:00.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":540000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The restricted stock unit award, granted as an annual performance award, vests as to 33.33% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof."}],"balance_after":1687281,"source":{"system":"sec-edgar","filing":"0000950170-25-075191","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000095017025075191/ownership.xml","form_type":"4"}},{"id":1140383,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-05-20T16:14:00.000Z","date":"2025-05-16","kind":"sale","planned":false,"acquired":false,"shares":13353,"price":0.58,"value":7744.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":1147281,"source":{"system":"sec-edgar","filing":"0000950170-25-075191","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000095017025075191/ownership.xml","form_type":"4"}},{"id":1177565,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37234,"kind":"person","name":"DENNER ALEXANDER J","position":1,"cik":"0001361754","reported_name":"DENNER ALEXANDER J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71303,"kind":"organization","name":"Sarissa Capital Management LP","position":2,"cik":"0001577524","reported_name":"Sarissa Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-04-04T20:05:07.000Z","date":"2025-04-02","kind":"grant","planned":false,"acquired":true,"shares":10416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024."}],"balance_after":166769,"source":{"system":"sec-edgar","filing":"0000950170-25-051106","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017025051106/ownership.xml","form_type":"4"}},{"id":1271518,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":31202,"kind":"person","name":"Silver Ronald","position":1,"cik":"0001873731","reported_name":"Silver Ronald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Class A Common Stock","published_at":"2025-02-13T02:00:10.000Z","date":"2025-02-10","kind":"sale","planned":false,"acquired":false,"shares":12048,"price":1.76,"value":21204.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.60 to $1.84, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":279655,"source":{"system":"sec-edgar","filing":"0000950170-25-019236","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017025019236/ownership.xml","form_type":"4"}},{"id":1272030,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":45734,"kind":"person","name":"Martini Gregory S.","position":1,"cik":"0002053936","reported_name":"Martini Gregory S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-02-13T02:00:05.000Z","date":"2025-02-10","kind":"sale","planned":false,"acquired":false,"shares":12052,"price":1.76,"value":21211.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.60 to $1.84, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":183810,"source":{"system":"sec-edgar","filing":"0000950170-25-019233","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2053936/000095017025019233/ownership.xml","form_type":"4"}},{"id":1271592,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-02-12T21:00:11.000Z","date":"2025-02-10","kind":"sale","planned":false,"acquired":false,"shares":139064,"price":1.76,"value":244752.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units and performance-based restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.60 to $1.84, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":1160634,"source":{"system":"sec-edgar","filing":"0000950170-25-019237","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000095017025019237/ownership.xml","form_type":"4"}},{"id":1272458,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":61367,"kind":"person","name":"Shetzline Michael","position":1,"cik":"0001808509","reported_name":"Shetzline Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CMO, Head-Res&Drug"}}],"security":"Class A Common Stock","published_at":"2025-02-12T21:00:08.000Z","date":"2025-02-10","kind":"sale","planned":false,"acquired":false,"shares":41269,"price":1.76,"value":72633.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units and performance-based restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.60 to $1.84, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":554007,"source":{"system":"sec-edgar","filing":"0000950170-25-019235","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808509/000095017025019235/ownership.xml","form_type":"4"}},{"id":1272457,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":61367,"kind":"person","name":"Shetzline Michael","position":1,"cik":"0001808509","reported_name":"Shetzline Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CMO, Head-Res&Drug"}}],"security":"Class A Common Stock","published_at":"2025-02-12T21:00:08.000Z","date":"2025-02-10","kind":"grant","planned":false,"acquired":true,"shares":133333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof."}],"balance_after":595276,"source":{"system":"sec-edgar","filing":"0000950170-25-019235","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808509/000095017025019235/ownership.xml","form_type":"4"}},{"id":1271921,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":61273,"kind":"person","name":"John Minardo","position":1,"cik":"0001875067","reported_name":"John Minardo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Class A Common Stock","published_at":"2025-02-12T21:00:07.000Z","date":"2025-02-10","kind":"sale","planned":false,"acquired":false,"shares":38938,"price":1.76,"value":68530.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units and performance-based restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.60 to $1.84, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":408132,"source":{"system":"sec-edgar","filing":"0000950170-25-019234","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875067/000095017025019234/ownership.xml","form_type":"4"}},{"id":1271920,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":61273,"kind":"person","name":"John Minardo","position":1,"cik":"0001875067","reported_name":"John Minardo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Class A Common Stock","published_at":"2025-02-12T21:00:07.000Z","date":"2025-02-10","kind":"grant","planned":false,"acquired":true,"shares":122222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof."}],"balance_after":447070,"source":{"system":"sec-edgar","filing":"0000950170-25-019234","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875067/000095017025019234/ownership.xml","form_type":"4"}},{"id":1291793,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":31202,"kind":"person","name":"Silver Ronald","position":1,"cik":"0001873731","reported_name":"Silver Ronald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Class A Common Stock","published_at":"2025-01-29T22:30:53.000Z","date":"2025-01-27","kind":"grant","planned":false,"acquired":true,"shares":133333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock unit award, granted as a promotion award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof."}],"balance_after":291703,"source":{"system":"sec-edgar","filing":"0000950170-25-010598","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017025010598/ownership.xml","form_type":"4"}},{"id":1292059,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":45734,"kind":"person","name":"Martini Gregory S.","position":1,"cik":"0002053936","reported_name":"Martini Gregory S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-01-29T22:30:12.000Z","date":"2025-01-27","kind":"grant","planned":false,"acquired":true,"shares":111111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock unit award, granted as a promotion award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof."}],"balance_after":195862,"source":{"system":"sec-edgar","filing":"0000950170-25-010597","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2053936/000095017025010597/ownership.xml","form_type":"4"}},{"id":1298229,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":61367,"kind":"person","name":"Shetzline Michael","position":1,"cik":"0001808509","reported_name":"Shetzline Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CMO, Head-Res&Drug"}}],"security":"Class A Common Stock","published_at":"2025-01-22T17:04:41.000Z","date":"2025-01-17","kind":"grant","planned":false,"acquired":true,"shares":48224,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares earned upon satisfaction of certain performance criteria associated with performance-based restricted stock units (PSUs) granted March 2, 2022. The earned PSUs were certified and vested on January 17, 2025."}],"balance_after":461943,"source":{"system":"sec-edgar","filing":"0000950170-25-007852","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808509/000095017025007852/ownership.xml","form_type":"4"}},{"id":1297819,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":61273,"kind":"person","name":"John Minardo","position":1,"cik":"0001875067","reported_name":"John Minardo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Class A Common Stock","published_at":"2025-01-22T16:38:44.000Z","date":"2025-01-17","kind":"grant","planned":false,"acquired":true,"shares":40187,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares earned upon satisfaction of certain performance criteria associated with performance-based restricted stock units (PSUs) granted March 2, 2022. The earned PSUs were certified and vested on January 17, 2025."}],"balance_after":324848,"source":{"system":"sec-edgar","filing":"0000950170-25-007815","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875067/000095017025007815/ownership.xml","form_type":"4"}},{"id":1297451,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-01-22T16:35:33.000Z","date":"2025-01-17","kind":"grant","planned":false,"acquired":true,"shares":147354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares earned upon satisfaction of certain performance criteria associated with performance-based restricted stock units (PSUs) granted March 8, 2022. The earned PSUs were certified and vested on January 17, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person acquired 2,014 shares of Class A Common Stock under the issuer's employee stock purchase plan on June 30, 2024."}],"balance_after":1299698,"source":{"system":"sec-edgar","filing":"0000950170-25-007805","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000095017025007805/ownership.xml","form_type":"4"}},{"id":1326549,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37234,"kind":"person","name":"DENNER ALEXANDER J","position":1,"cik":"0001361754","reported_name":"DENNER ALEXANDER J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71303,"kind":"organization","name":"Sarissa Capital Management LP","position":2,"cik":"0001577524","reported_name":"Sarissa Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-12-18T21:05:02.000Z","date":"2024-12-16","kind":"grant","planned":false,"acquired":true,"shares":4249,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024."}],"balance_after":156353,"source":{"system":"sec-edgar","filing":"0000950170-24-137870","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017024137870/ownership.xml","form_type":"4"}},{"id":1357112,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":85861,"kind":"person","name":"Davis Andrew","position":1,"cik":"0001932525","reported_name":"Davis Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2024-11-20T21:05:04.000Z","date":"2024-11-18","kind":"sale","planned":false,"acquired":false,"shares":5360,"price":4.08,"value":21868.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person acquired 2,014 shares of Class A Common Stock under the issuer's employee stock purchase plan on June 30, 2024."}],"balance_after":284685,"source":{"system":"sec-edgar","filing":"0000950170-24-129228","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017024129228/ownership.xml","form_type":"4"}},{"id":1357111,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37711,"kind":"person","name":"Emany Sravan Kumar","position":1,"cik":"0001897662","reported_name":"Emany Sravan Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO and CFO"}}],"security":"Class A Common Stock","published_at":"2024-11-20T21:05:03.000Z","date":"2024-11-18","kind":"sale","planned":false,"acquired":false,"shares":11001,"price":4.08,"value":44884.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":309572,"source":{"system":"sec-edgar","filing":"0000950170-24-129227","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017024129227/ownership.xml","form_type":"4"}},{"id":1403499,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37234,"kind":"person","name":"DENNER ALEXANDER J","position":1,"cik":"0001361754","reported_name":"DENNER ALEXANDER J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71303,"kind":"organization","name":"Sarissa Capital Management LP","position":2,"cik":"0001577524","reported_name":"Sarissa Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-09-18T20:05:08.000Z","date":"2024-09-16","kind":"grant","planned":false,"acquired":true,"shares":3282,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024."}],"balance_after":152104,"source":{"system":"sec-edgar","filing":"0000950170-24-107770","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017024107770/ownership.xml","form_type":"4"}},{"id":1433558,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":31202,"kind":"person","name":"Silver Ronald","position":1,"cik":"0001873731","reported_name":"Silver Ronald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Class A Common Stock","published_at":"2024-08-14T21:08:21.000Z","date":"2024-08-12","kind":"sale","planned":false,"acquired":false,"shares":3107,"price":4.27,"value":13266.89,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":158370,"source":{"system":"sec-edgar","filing":"0000950170-24-097182","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017024097182/ownership.xml","form_type":"4"}},{"id":1433879,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":61273,"kind":"person","name":"John Minardo","position":1,"cik":"0001875067","reported_name":"John Minardo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Class A Common Stock","published_at":"2024-08-14T17:10:28.000Z","date":"2024-08-12","kind":"sale","planned":false,"acquired":false,"shares":9910,"price":4.27,"value":42315.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":284661,"source":{"system":"sec-edgar","filing":"0000950170-24-097189","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875067/000095017024097189/ownership.xml","form_type":"4"}},{"id":1471952,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":30802,"kind":"person","name":"Shepard Jay","position":1,"cik":"0001587788","reported_name":"Shepard Jay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-06-21T20:05:13.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":24311,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":126555,"source":{"system":"sec-edgar","filing":"0000950170-24-076213","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017024076213/ownership.xml","form_type":"4"}},{"id":1472047,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":47389,"kind":"person","name":"Dreyfus Andrew","position":1,"cik":"0001670893","reported_name":"Dreyfus Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-06-21T20:05:11.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":24311,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Since the date of the reporting person's last ownership report, the individual transferred 5,061 shares of Class A common stock to the individual's ex-spouse pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by the individual's ex-spouse."}],"balance_after":188230,"source":{"system":"sec-edgar","filing":"0000950170-24-076211","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670893/000095017024076211/ownership.xml","form_type":"4"}},{"id":1471951,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37235,"kind":"person","name":"Duane Jon R","position":1,"cik":"0001772129","reported_name":"Duane Jon R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-06-21T20:05:09.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":24311,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":145339,"source":{"system":"sec-edgar","filing":"0000950170-24-076209","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017024076209/ownership.xml","form_type":"4"}},{"id":1471995,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-06-21T20:05:08.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":24311,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":163839,"source":{"system":"sec-edgar","filing":"0000950170-24-076210","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000095017024076210/ownership.xml","form_type":"4"}},{"id":1471949,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":36673,"kind":"person","name":"Moukheibir Catherine","position":1,"cik":"0001772130","reported_name":"Moukheibir Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-06-21T20:05:08.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":24311,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":72944,"source":{"system":"sec-edgar","filing":"0000950170-24-076220","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017024076220/ownership.xml","form_type":"4"}},{"id":1471950,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37236,"kind":"person","name":"Kessler Marla L","position":1,"cik":"0001772124","reported_name":"Kessler Marla L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-06-21T20:05:05.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":24311,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":120883,"source":{"system":"sec-edgar","filing":"0000950170-24-076207","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017024076207/ownership.xml","form_type":"4"}},{"id":1471948,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37234,"kind":"person","name":"DENNER ALEXANDER J","position":1,"cik":"0001361754","reported_name":"DENNER ALEXANDER J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71303,"kind":"organization","name":"Sarissa Capital Management LP","position":2,"cik":"0001577524","reported_name":"Sarissa Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-06-21T20:05:04.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":24311,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":148822,"source":{"system":"sec-edgar","filing":"0000950170-24-076216","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017024076216/ownership.xml","form_type":"4"}},{"id":1471994,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37245,"kind":"person","name":"Currie Mark G","position":1,"cik":"0001478244","reported_name":"Currie Mark G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-06-21T20:05:03.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":24311,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":568419,"source":{"system":"sec-edgar","filing":"0000950170-24-076206","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478244/000095017024076206/ownership.xml","form_type":"4"}},{"id":1475104,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37234,"kind":"person","name":"DENNER ALEXANDER J","position":1,"cik":"0001361754","reported_name":"DENNER ALEXANDER J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71303,"kind":"organization","name":"Sarissa Capital Management LP","position":2,"cik":"0001577524","reported_name":"Sarissa Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-06-18T20:05:03.000Z","date":"2024-06-15","kind":"grant","planned":false,"acquired":true,"shares":2572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024."}],"balance_after":124511,"source":{"system":"sec-edgar","filing":"0000950170-24-074833","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017024074833/ownership.xml","form_type":"4"}},{"id":1482023,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-06-12T20:05:03.000Z","date":"2024-06-10","kind":"sale","planned":true,"acquired":false,"shares":22766,"price":6.29,"value":143198.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.95 to $6.55, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":139528,"source":{"system":"sec-edgar","filing":"0000950170-24-072417","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000095017024072417/ownership.xml","form_type":"4"}},{"id":1484783,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":36673,"kind":"person","name":"Moukheibir Catherine","position":1,"cik":"0001772130","reported_name":"Moukheibir Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-06-10T20:58:50.000Z","date":"2024-06-07","kind":"sale","planned":false,"acquired":false,"shares":35574,"price":6.61,"value":235144.14,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.56 to $6.65, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":48633,"source":{"system":"sec-edgar","filing":"0000950170-24-071393","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017024071393/ownership.xml","form_type":"4"}},{"id":1484782,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":36673,"kind":"person","name":"Moukheibir Catherine","position":1,"cik":"0001772130","reported_name":"Moukheibir Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-06-10T20:58:50.000Z","date":"2024-06-06","kind":"sale","planned":false,"acquired":false,"shares":44426,"price":6.36,"value":282549.36,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.30 to $6.43, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":84207,"source":{"system":"sec-edgar","filing":"0000950170-24-071393","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017024071393/ownership.xml","form_type":"4"}},{"id":1505338,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":85861,"kind":"person","name":"Davis Andrew","position":1,"cik":"0001932525","reported_name":"Davis Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2024-05-22T20:05:19.000Z","date":"2024-05-20","kind":"sale","planned":false,"acquired":false,"shares":22725,"price":6.45,"value":146576.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units and performance-based restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":288031,"source":{"system":"sec-edgar","filing":"0000950170-24-063482","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017024063482/ownership.xml","form_type":"4"}},{"id":1505404,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-05-22T16:05:26.000Z","date":"2024-05-20","kind":"sale","planned":false,"acquired":false,"shares":67618,"price":6.45,"value":436136.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units and performance-based restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":1150330,"source":{"system":"sec-edgar","filing":"0000950170-24-063485","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000095017024063485/ownership.xml","form_type":"4"}},{"id":1506160,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":61367,"kind":"person","name":"Shetzline Michael","position":1,"cik":"0001808509","reported_name":"Shetzline Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO,SVP,Head-Res&Drug"}}],"security":"Class A Common Stock","published_at":"2024-05-22T16:05:12.000Z","date":"2024-05-20","kind":"sale","planned":false,"acquired":false,"shares":16128,"price":6.45,"value":104025.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":413719,"source":{"system":"sec-edgar","filing":"0000950170-24-063481","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808509/000095017024063481/ownership.xml","form_type":"4"}},{"id":1505728,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":61273,"kind":"person","name":"John Minardo","position":1,"cik":"0001875067","reported_name":"John Minardo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Class A Common Stock","published_at":"2024-05-22T16:05:09.000Z","date":"2024-05-20","kind":"sale","planned":false,"acquired":false,"shares":17404,"price":6.45,"value":112255.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":294571,"source":{"system":"sec-edgar","filing":"0000950170-24-063480","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875067/000095017024063480/ownership.xml","form_type":"4"}},{"id":1508892,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37711,"kind":"person","name":"Emany Sravan Kumar","position":1,"cik":"0001897662","reported_name":"Emany Sravan Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-05-20T20:05:24.000Z","date":"2024-05-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":18280,"price":6.64,"value":121379.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units."}],"balance_after":320573,"source":{"system":"sec-edgar","filing":"0000950170-24-062372","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017024062372/ownership.xml","form_type":"4"}},{"id":1568337,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37234,"kind":"person","name":"DENNER ALEXANDER J","position":1,"cik":"0001361754","reported_name":"DENNER ALEXANDER J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71303,"kind":"organization","name":"Sarissa Capital Management LP","position":2,"cik":"0001577524","reported_name":"Sarissa Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-03-19T20:05:25.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":1662,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024."}],"balance_after":121939,"source":{"system":"sec-edgar","filing":"0000950170-24-033454","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017024033454/ownership.xml","form_type":"4"}},{"id":1580938,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37711,"kind":"person","name":"Emany Sravan Kumar","position":1,"cik":"0001897662","reported_name":"Emany Sravan Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Performance-based Restricted Stock Unit","published_at":"2024-03-12T20:05:21.000Z","date":"2024-03-08","kind":"exercise","planned":false,"acquired":false,"shares":37120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each PSU represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs are earned upon the Issuer's Class A Common Stock achieving a specified price per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each PSU represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs are earned upon the Issuer's Class A Common Stock achieving a specified price per share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Additional PSUs may vest upon the Issuer's Class A Common Stock achieving specified prices per share beyond the previously achieved vesting targets."}],"balance_after":0,"derivative":{"expiration_date":"2026-02-28","underlying":"Class A Common Stock","underlying_shares":37120},"source":{"system":"sec-edgar","filing":"0000950170-24-029907","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017024029907/ownership.xml","form_type":"4"}},{"id":1580937,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37711,"kind":"person","name":"Emany Sravan Kumar","position":1,"cik":"0001897662","reported_name":"Emany Sravan Kumar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-03-12T20:05:21.000Z","date":"2024-03-08","kind":"exercise","planned":false,"acquired":true,"shares":37120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares earned upon satisfaction of certain performance criteria associated with performance-based restricted stock units (PSUs) granted on March 8, 2023. The earned PSUs were certified on February 12, 2024, and March 7, 2024, and vested on March 8, 2024."}],"balance_after":338853,"source":{"system":"sec-edgar","filing":"0000950170-24-029907","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017024029907/ownership.xml","form_type":"4"}},{"id":1580936,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":85861,"kind":"person","name":"Davis Andrew","position":1,"cik":"0001932525","reported_name":"Davis Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Performance-based Restricted Stock Unit","published_at":"2024-03-12T20:05:10.000Z","date":"2024-03-08","kind":"exercise","planned":false,"acquired":false,"shares":37120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each PSU represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs are earned upon the Issuer's Class A Common Stock achieving a specified price per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each PSU represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs are earned upon the Issuer's Class A Common Stock achieving a specified price per share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Additional PSUs may vest upon the Issuer's Class A Common Stock achieving specified prices per share beyond the previously achieved vesting targets."}],"balance_after":0,"derivative":{"expiration_date":"2026-02-28","underlying":"Class A Common Stock","underlying_shares":37120},"source":{"system":"sec-edgar","filing":"0000950170-24-029910","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017024029910/ownership.xml","form_type":"4"}},{"id":1580935,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":85861,"kind":"person","name":"Davis Andrew","position":1,"cik":"0001932525","reported_name":"Davis Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2024-03-12T20:05:10.000Z","date":"2024-03-08","kind":"exercise","planned":false,"acquired":true,"shares":37120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares earned upon satisfaction of certain performance criteria associated with performance-based restricted stock units (PSUs) granted on March 8, 2023. The earned PSUs were certified on February 12, 2024, and March 7, 2024, and vested on March 8, 2024."}],"balance_after":310756,"source":{"system":"sec-edgar","filing":"0000950170-24-029910","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017024029910/ownership.xml","form_type":"4"}},{"id":1581619,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":61273,"kind":"person","name":"John Minardo","position":1,"cik":"0001875067","reported_name":"John Minardo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Performance-based Restricted Stock Unit","published_at":"2024-03-12T16:05:22.000Z","date":"2024-03-08","kind":"exercise","planned":false,"acquired":false,"shares":32752,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each PSU represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs are earned upon the Issuer's Class A Common Stock achieving a specified price per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each PSU represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs are earned upon the Issuer's Class A Common Stock achieving a specified price per share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Additional PSUs may vest upon the Issuer's Class A Common Stock achieving specified prices per share beyond the previously achieved vesting targets."}],"balance_after":0,"derivative":{"expiration_date":"2026-02-28","underlying":"Class A Common Stock","underlying_shares":32752},"source":{"system":"sec-edgar","filing":"0000950170-24-029908","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875067/000095017024029908/ownership.xml","form_type":"4"}},{"id":1581618,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":61273,"kind":"person","name":"John Minardo","position":1,"cik":"0001875067","reported_name":"John Minardo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Class A Common Stock","published_at":"2024-03-12T16:05:22.000Z","date":"2024-03-08","kind":"exercise","planned":false,"acquired":true,"shares":32752,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares earned upon satisfaction of certain performance criteria associated with performance-based restricted stock units (PSUs) granted on March 8, 2023. The earned PSUs were certified on February 12, 2024, and March 7, 2024, and vested on March 8, 2024."}],"balance_after":311975,"source":{"system":"sec-edgar","filing":"0000950170-24-029908","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875067/000095017024029908/ownership.xml","form_type":"4"}},{"id":1582345,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":61367,"kind":"person","name":"Shetzline Michael","position":1,"cik":"0001808509","reported_name":"Shetzline Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO,SVP,Head-Res&Drug"}}],"security":"Performance-based Restricted Stock Unit","published_at":"2024-03-12T16:05:16.000Z","date":"2024-03-08","kind":"exercise","planned":false,"acquired":false,"shares":34936,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each PSU represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs are earned upon the Issuer's Class A Common Stock achieving a specified price per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each PSU represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs are earned upon the Issuer's Class A Common Stock achieving a specified price per share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Additional PSUs may vest upon the Issuer's Class A Common Stock achieving specified prices per share beyond the previously achieved vesting targets."}],"balance_after":0,"derivative":{"expiration_date":"2026-02-28","underlying":"Class A Common Stock","underlying_shares":34936},"source":{"system":"sec-edgar","filing":"0000950170-24-029906","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808509/000095017024029906/ownership.xml","form_type":"4"}},{"id":1582344,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":61367,"kind":"person","name":"Shetzline Michael","position":1,"cik":"0001808509","reported_name":"Shetzline Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO,SVP,Head-Res&Drug"}}],"security":"Class A Common Stock","published_at":"2024-03-12T16:05:16.000Z","date":"2024-03-08","kind":"exercise","planned":false,"acquired":true,"shares":34936,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares earned upon satisfaction of certain performance criteria associated with performance-based restricted stock units (PSUs) granted on March 8, 2023. The earned PSUs were certified on February 12, 2024, and March 7, 2024, and vested on March 8, 2024."}],"balance_after":429847,"source":{"system":"sec-edgar","filing":"0000950170-24-029906","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808509/000095017024029906/ownership.xml","form_type":"4"}},{"id":1581010,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":38715,"kind":"person","name":"MCCOURT Thomas A","position":1,"cik":"0001478448","reported_name":"MCCOURT Thomas A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance-based Restricted Stock Unit","published_at":"2024-03-12T16:05:07.000Z","date":"2024-03-08","kind":"exercise","planned":false,"acquired":false,"shares":120298,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each PSU represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs are earned upon the Issuer's Class A Common Stock achieving a specified price per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each PSU represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs are earned upon the Issuer's Class A Common Stock achieving a specified price per share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Additional PSUs may vest upon the Issuer's Class A Common Stock achieving specified prices per share beyond the previously achieved vesting targets."}],"balance_after":0,"derivative":{"expiration_date":"2026-02-28","underlying":"Class A Common Stock","underlying_shares":120298},"source":{"system":"sec-edgar","filing":"0000950170-24-029909","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478448/000095017024029909/ownership.xml","form_type":"4"}}],"next_cursor":"2024-03-12T16:05:07.000000Z,1581010"}